Quarterly report · Q2
4452.TEDINET S100OY5H
Period2022-01-01 → 2022-06-30
Filed2022-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥733.9bn | 2022-01-01 → 2022-06-30 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥387.1bn | 2022-04-01 → 2022-06-30d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.42T | 2021-01-01 → 2021-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥675.2bn | 2021-01-01 → 2021-06-30 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥354.6bn | 2021-04-01 → 2021-06-30d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥53.7bn | 2022-01-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥30.7bn | 2022-04-01 → 2022-06-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥70.6bn | 2021-01-01 → 2021-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥39.6bn | 2021-04-01 → 2021-06-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥60.5bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥34.8bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥150.0bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥74.1bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥40.2bn | 2021-04-01 → 2021-06-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥38.9bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥20.6bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥109.6bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥52.5bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥26.8bn | 2021-04-01 → 2021-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥39.8bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥21.0bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss IFRS |
| Net income | ¥53.5bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥27.2bn | 2021-04-01 → 2021-06-30d | Cons. | Profit loss IFRS |
| Total assets | ¥1.76T | at 2022-06-30 | Cons. | Assets IFRS |
| Total assets | ¥1.70T | at 2021-12-31 | Cons. | Assets IFRS |
| Total assets | ¥1.62T | at 2021-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥721.4bn | at 2022-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥720.1bn | at 2021-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.04T | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥983.9bn | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥932.7bn | at 2021-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥938.2bn | at 2020-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.02T | at 2022-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥965.1bn | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥915.8bn | at 2021-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥280.5bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥336.1bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥296.1bn | at 2021-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥353.2bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥27.7bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥175.5bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥64.6bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥40.0bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥67.2bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥34.7bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥67.2bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥141.6bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥96.6bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥82.17 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥43.67 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥230.59 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥110.12 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥56.53 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥82.16 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥43.67 | 2022-04-01 → 2022-06-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥230.57 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥110.12 | 2021-01-01 → 2021-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥56.52 | 2021-04-01 → 2021-06-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 57.7% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 56.6% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 56.5% | at 2021-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 16
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | ¥196m |
| jpcrp040300-q2r_E00883-000Chemical Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥20.1bn |
| jpcrp040300-q2r_E00883-000Consumer Products Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥33.3bn |
| jpcrp040300-q2r_E00883-000Cosmetics Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥2.2bn |
| jpcrp040300-q2r_E00883-000Health And Beauty Care Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥18.2bn |
| jpcrp040300-q2r_E00883-000Hygiene And Living Care Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥13.1bn |
| jpcrp040300-q2r_E00883-000Life Care Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥104m |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥53.5bn |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-06-30 | ¥357m |
| jpcrp040300-q2r_E00883-000Chemical Businessreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥16.8bn |
| jpcrp040300-q2r_E00883-000Consumer Products Businessreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥53.4bn |
| jpcrp040300-q2r_E00883-000Cosmetics Businessreportable segment | segment profit | 2021-01-01 → 2021-06-30 | −¥477m |
| jpcrp040300-q2r_E00883-000Health And Beauty Care Businessreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥26.3bn |
| jpcrp040300-q2r_E00883-000Hygiene And Living Care Businessreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥26.0bn |
| jpcrp040300-q2r_E00883-000Life Care Businessreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥1.6bn |
| —segment total | segment profit | 2021-01-01 → 2021-06-30 | ¥70.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 858
| Item | Context | Value | Unit |
|---|---|---|---|
| Other fin cf IFRS | Prior1YTDDuration | 802000000 | JPY |
| Other fin cf IFRS | CurrentYTDDuration | 2042000000 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1YTDDuration | -96622000000 | JPY |
| Net cash provided by used in financing activities IFRS | CurrentYTDDuration | -67238000000 | JPY |
| Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRS | Prior1YTDDuration | -66689000000 | JPY |
| Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRS | CurrentYTDDuration | -79543000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 353176000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 336069000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1YTDDuration | 9640000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | CurrentYTDDuration | 24001000000 | JPY |
| Cash and cash equivalents IFRS | Prior1QuarterInstant | 296127000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 280527000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | 234772000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | 173959000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000LifeCareBusinessReportableSegmentMember | 24867000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000CosmeticsBusinessReportableSegmentMember | 110576000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000ConsumerProductsBusinessReportableSegmentMember | 544174000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000ChemicalBusinessReportableSegmentMember | 131005000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_ReportableSegmentsMember | 675179000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Sales to external customers IFRS | Prior1YTDDuration | 675179000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000LifeCareBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000CosmeticsBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000ConsumerProductsBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000ChemicalBusinessReportableSegmentMember | 19398000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_ReportableSegmentsMember | 19398000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_ReconcilingItemsMember | -19398000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration | - | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | 234772000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | 173959000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000LifeCareBusinessReportableSegmentMember | 24867000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000CosmeticsBusinessReportableSegmentMember | 110576000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000ConsumerProductsBusinessReportableSegmentMember | 544174000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000ChemicalBusinessReportableSegmentMember | 150403000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_ReportableSegmentsMember | 694577000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_ReconcilingItemsMember | -19398000000 | JPY |
| Net sales IFRS | Prior1YTDDuration | 675179000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | 26048000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | 26296000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000LifeCareBusinessReportableSegmentMember | 1571000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000CosmeticsBusinessReportableSegmentMember | -477000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000ConsumerProductsBusinessReportableSegmentMember | 53438000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00883-000ChemicalBusinessReportableSegmentMember | 16756000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_ReportableSegmentsMember | 70194000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_ReconcilingItemsMember | 357000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration | 70551000000 | JPY |
| Finance income IFRS | Prior1YTDDuration | 3537000000 | JPY |
| Finance costs IFRS | Prior1YTDDuration | 1297000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |